omniture
德琪医药/德琪(浙江)医药科技有限公司

Latest News

Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors

SHANGHAI and PHILADELPHIA, Jan. 8, 2020 /PRNewswire/ -- The Antengene board today announced the app...

2020-01-08 20:00 1318

Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer

SHANGHAI and PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ -- Antengene Corporation today announced its a...

2020-01-06 20:00 777

Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364

SHANGHAI and LONDON, Nov. 7, 2019 /PRNewswire/ -- Antengene Corporation today announced that it has...

2019-11-07 01:40 874

Antengene Corporation Announces Establishment of U.S. Subsidiary and Collaboration with the Baruch S. Blumberg Institute

SHANGHAI, April 8, 2019 /PRNewswire/ -- Antengene Corporation, a clinical stage biopharmaceutical ...

2019-04-08 20:00 1097

Antengene Corporation Raises $120 Million in Series B Financing

SHANGHAI and SHAOXING, China, Jan. 2, 2019 /PRNewswire/ -- Antengene Corporation (Antengene), a cl...

2019-01-02 08:45 1333